The Asia Pacific Cough Remedies Market would witness market growth of 6.0% CAGR during the forecast period (2023-2030).
The China market dominated the Asia Pacific Cough Remedies Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $823.4 million by 2030. The Japan market is registering a CAGR of 5.3% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 6.6% during (2023 - 2030).
Manufacturers are increasingly formulating combination cough remedies targeting multiple symptoms or underlying causes of cough. These formulations often integrate cough suppressants, expectorants, antihistamines, and analgesics to provide comprehensive relief from cough and associated symptoms such as congestion, pain, and inflammation. Combination cough remedies offer several advantages over single-ingredient formulations, including enhanced convenience, simplified dosing regimens, and improved patient compliance. By consolidating multiple active ingredients into a single product, manufacturers streamline the treatment process, reducing the need for individuals to purchase and administer multiple medications separately.
Additionally, Advances in pharmacology and understanding of cough pathophysiology have led to targeted therapies tailored to specific cough types and mechanisms. Examples include neuromodulators targeting cough reflex pathways, mucus-modifying agents to enhance airway clearance, and immunomodulators addressing inflammatory cough conditions. These agents can suppress cough hypersensitivity and reduce cough frequency by modulating neuronal signaling in the central nervous system or peripheral nerves. Such precision in targeting underlying neurogenic mechanisms holds promise for treating refractory or chronic cough conditions.
The rising cases of respiratory diseases in Australia are expected to impact the demand for cough remedies directly. As per the Government of Australia, based on self-reported data from NHS 2020-21, nearly 30% of Australians said they had long-term respiratory illnesses. Thus, the rising pharmaceutical sector and increasing respiratory disease cases in the Asia Pacific will propel the demand for cough remedies in the region.
Based on Age, the market is segmented into Adult and Pediatric. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital and Online Pharmacies. Based on Type, the market is segmented into Expectorants, Antihistamines, Bronchodilators, Antibiotics and Others. Based on Dosage, the market is segmented into Oral Syrup, Tablets & Pills, Lozenges, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The China market dominated the Asia Pacific Cough Remedies Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $823.4 million by 2030. The Japan market is registering a CAGR of 5.3% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 6.6% during (2023 - 2030).
Manufacturers are increasingly formulating combination cough remedies targeting multiple symptoms or underlying causes of cough. These formulations often integrate cough suppressants, expectorants, antihistamines, and analgesics to provide comprehensive relief from cough and associated symptoms such as congestion, pain, and inflammation. Combination cough remedies offer several advantages over single-ingredient formulations, including enhanced convenience, simplified dosing regimens, and improved patient compliance. By consolidating multiple active ingredients into a single product, manufacturers streamline the treatment process, reducing the need for individuals to purchase and administer multiple medications separately.
Additionally, Advances in pharmacology and understanding of cough pathophysiology have led to targeted therapies tailored to specific cough types and mechanisms. Examples include neuromodulators targeting cough reflex pathways, mucus-modifying agents to enhance airway clearance, and immunomodulators addressing inflammatory cough conditions. These agents can suppress cough hypersensitivity and reduce cough frequency by modulating neuronal signaling in the central nervous system or peripheral nerves. Such precision in targeting underlying neurogenic mechanisms holds promise for treating refractory or chronic cough conditions.
The rising cases of respiratory diseases in Australia are expected to impact the demand for cough remedies directly. As per the Government of Australia, based on self-reported data from NHS 2020-21, nearly 30% of Australians said they had long-term respiratory illnesses. Thus, the rising pharmaceutical sector and increasing respiratory disease cases in the Asia Pacific will propel the demand for cough remedies in the region.
Based on Age, the market is segmented into Adult and Pediatric. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital and Online Pharmacies. Based on Type, the market is segmented into Expectorants, Antihistamines, Bronchodilators, Antibiotics and Others. Based on Dosage, the market is segmented into Oral Syrup, Tablets & Pills, Lozenges, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Himalaya Global Holdings Ltd.
- Nature's Way Products LLC (Dr. Willmar Schwabe GmbH & Co. KG)
- Pfizer, Inc.
- Amway Corporation
- NOW Foods, Inc.
- Wakunaga of America Co., Ltd. (Wakunaga Pharmaceutical Co., Ltd.)
- Nu Skin Enterprises, Inc.
- Nature’s Sunshine Products, Inc.
- Neurobiologix, Inc.
- Nordic Naturals, Inc.
Market Report Segmentation
By Age- Adult
- Pediatric
- Retail Pharmacy
- Hospital
- Online Pharmacies
- Expectorants
- Antihistamines
- Bronchodilators
- Antibiotics
- Others
- Oral Syrup
- Tablets & Pills
- Lozenges
- Others
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Asia Pacific Cough Remedies Market by Age
Chapter 5. Asia Pacific Cough Remedies Market by Distribution Channel
Chapter 6. Asia Pacific Cough Remedies Market by Type
Chapter 7. Asia Pacific Cough Remedies Market by Dosage
Chapter 8. Asia Pacific Cough Remedies Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Himalaya Global Holdings Ltd.
- Nature's Way Products LLC (Dr. Willmar Schwabe GmbH & Co. KG)
- Pfizer, Inc.
- Amway Corporation
- NOW Foods, Inc.
- Wakunaga of America Co., Ltd. (Wakunaga Pharmaceutical Co., Ltd.)
- Nu Skin Enterprises, Inc.
- Nature’s Sunshine Products, Inc.
- Neurobiologix, Inc.
- Nordic Naturals, Inc.
Methodology
LOADING...
